Location History:
- Milton, MA (US) (1999 - 2009)
- Charlestown, MA (US) (2005 - 2014)
- Nahant, MA (US) (2015 - 2016)
Company Filing History:
7 out of 2,890 
2 out of 8,373 
1 out of 389 
Years Active: 1999-2016
Title: Bruce D Walker: Innovator in Targeted Therapeutics
Introduction
Bruce D Walker is a prominent inventor based in Nahant, MA (US), known for his significant contributions to the field of targeted therapeutics. With a total of 9 patents, Walker has focused on developing innovative methods for delivering agents to virally infected cells and tissues.
Latest Patents
One of his latest patents is titled "Methods and compositions for localized delivery of agents to virally infected cells and tissues." This invention provides compositions and methods for delivering an agent to virally infected tissues and/or cells of a subject by conjugating agent-loaded nanoparticles to virus-specific T cells, such as cytotoxic T lymphocytes. The agent may include a latency-reversing drug (LRD), an antiviral agent, and/or an agent that enhances the cytotoxic efficacy of T lymphocytes. Another notable patent is "Compositions and methods for assessing cytotoxicity of single cells," which offers a method for analyzing interactions between pairs of target and effector cells utilizing high-throughput screening methods for profiling large numbers of single cells in microarrays.
Career Highlights
Throughout his career, Bruce D Walker has worked with esteemed organizations such as The General Hospital Corporation and the Massachusetts Institute of Technology. His work has significantly advanced the understanding and treatment of viral infections.
Collaborations
Walker has collaborated with notable colleagues, including Ralf Geiben Lynn and Stephen H Herrmann, contributing to the advancement of research in his field.
Conclusion
In summary, Bruce D Walker is a distinguished inventor whose work in targeted therapeutics has led to multiple patents and collaborations with leading institutions. His innovative approaches continue to impact the field of medicine and improve treatment options for viral infections.